BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM, Condorelli G. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene. 2013;32:4001-4008. [PMID: 22964638 DOI: 10.1038/onc.2012.410] [Cited by in Crossref: 67] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Han W, Cui H, Liang J, Su X. Role of MicroRNA-30c in cancer progression. J Cancer 2020;11:2593-601. [PMID: 32201529 DOI: 10.7150/jca.38449] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 Zhang L, Jia X. Down-regulation of miR-30b-5p protects cardiomyocytes against hypoxia-induced injury by targeting Aven. Cell Mol Biol Lett 2019;24:61. [PMID: 31768184 DOI: 10.1186/s11658-019-0187-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Wang WY, Zhang HF, Wang L, Ma YP, Gao F, Zhang SJ, Wang LC. miR-21 expression predicts prognosis in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2014;38:715-719. [PMID: 25150373 DOI: 10.1016/j.clinre.2014.07.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
4 Chen S, Li P, Yang R, Cheng R, Zhang F, Wang Y, Chen X, Sun Q, Zang W, Du Y, Zhao G, Zhang G. microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer. Cancer Cell Int 2015;15:85. [PMID: 26388700 DOI: 10.1186/s12935-015-0236-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
5 Tan EH, Morton JP, Timpson P, Tucci P, Melino G, Flores ER, Sansom OJ, Vousden KH, Muller PA. Functions of TAp63 and p53 in restraining the development of metastatic cancer. Oncogene 2014;33:3325-33. [PMID: 23873029 DOI: 10.1038/onc.2013.287] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
6 Ilhan-Mutlu A, Wöhrer A, Berghoff AS, Widhalm G, Marosi C, Wagner L, Preusser M. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens. J Neurooncol 2013;112:347-54. [PMID: 23420397 DOI: 10.1007/s11060-013-1078-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
7 Zare A, Ganji M, Omrani MD, Alipoor B, Ghaedi H. Gastric Cancer MicroRNAs Meta-signature. Int J Mol Cell Med 2019;8:94-102. [PMID: 32215261 DOI: 10.22088/IJMCM.BUMS.8.2.94] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Zhao H, Xu Z, Qin H, Gao Z, Gao L. miR-30b regulates migration and invasion of human colorectal cancer via SIX1. Biochem J. 2014;460:117-125. [PMID: 24593661 DOI: 10.1042/bj20131535] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
9 Yeh WL, Lin HY, Huang CY, Huang BR, Lin C, Lu DY, Wei KC. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins. Oncotarget 2015;6:37770-81. [PMID: 26473373 DOI: 10.18632/oncotarget.6092] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
10 Zhang C, Pan X, Peng X, Liu K, Wang J, Zhao L, Chen X, Huang G, Li H, Ye J, Lai Y. miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer. J Clin Lab Anal 2021;35:e23599. [PMID: 33247622 DOI: 10.1002/jcla.23599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shao X, Zhang S, Tang Y, Kong W. Micro RNA‐30b (inhibitor) nanoparticles suppressed the lipopolysaccharide (LPS)‐induced acute kidney injury. IET nanobiotechnol 2019;13:923-7. [DOI: 10.1049/iet-nbt.2019.0110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Guicciardi ME, Gores GJ. Unshackling caspase-7 for cancer therapy. J Clin Invest 2013;123:3706-8. [PMID: 23979156 DOI: 10.1172/JCI71440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Fiore D, Donnarumma E, Roscigno G, Iaboni M, Russo V, Affinito A, Adamo A, De Martino F, Quintavalle C, Romano G, Greco A, Soini Y, Brunetti A, Croce CM, Condorelli G. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS. Oncotarget 2016;7:19531-47. [PMID: 26799668 DOI: 10.18632/oncotarget.6968] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
14 Wu J, Zheng C, Fan Y, Zeng C, Chen Z, Qin W, Zhang C, Zhang W, Wang X, Zhu X, Zhang M, Zen K, Liu Z. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol 2014;25:92-104. [PMID: 24029422 DOI: 10.1681/ASN.2012111101] [Cited by in Crossref: 114] [Cited by in F6Publishing: 64] [Article Influence: 12.7] [Reference Citation Analysis]
15 Wang SS, Feng L, Hu BG, Lu YF, Wang WM, Guo W, Suen CW, Jiao BH, Pang JX, Fu WM, Zhang JF. miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling. Mol Ther Nucleic Acids 2017;8:482-92. [PMID: 28918048 DOI: 10.1016/j.omtn.2017.07.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
16 Moreno-Mateos MA, Barragán V, Torres B, Rodríguez-Mateo C, Méndez-Vidal C, Berezikov E, Mudduluru G, Allgayer H, Pintor-Toro JA. Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance. RNA 2013;19:1711-25. [PMID: 24129493 DOI: 10.1261/rna.039461.113] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Donzelli S, Mori F, Biagioni F, Bellissimo T, Pulito C, Muti P, Strano S, Blandino G. MicroRNAs: short non-coding players in cancer chemoresistance. Mol Cell Ther 2014;2:16. [PMID: 26056584 DOI: 10.1186/2052-8426-2-16] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
18 Jin D, Lee H. Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets. Sci Rep 2016;6:35350. [PMID: 27734929 DOI: 10.1038/srep35350] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
19 Lee TJ, Yoo JY, Shu D, Li H, Zhang J, Yu JG, Jaime-Ramirez AC, Acunzo M, Romano G, Cui R, Sun HL, Luo Z, Old M, Kaur B, Guo P, Croce CM. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21. Mol Ther 2017;25:1544-55. [PMID: 28109960 DOI: 10.1016/j.ymthe.2016.11.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 13.0] [Reference Citation Analysis]
20 Zhang X, Zhang X, Hu S, Zheng M, Zhang J, Zhao J, Zhang X, Yan B, Jia L, Zhao J, Wu K, Yang A, Zhang R. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells. Nucleic Acids Res 2017;45:5930-44. [PMID: 28459998 DOI: 10.1093/nar/gkx317] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
21 Koshkin PA, Chistiakov DA, Nikitin AG, Konovalov AN, Potapov AA, Usachev DY, Pitskhelauri DI, Kobyakov GL, Shishkina LV, Chekhonin VP. Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades. Clin Chim Acta 2014;430:55-62. [PMID: 24412320 DOI: 10.1016/j.cca.2014.01.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
22 Scioli MG, Terriaca S, Fiorelli E, Storti G, Fabbri G, Cervelli V, Orlandi A. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives. Int J Mol Sci 2021;22:10572. [PMID: 34638913 DOI: 10.3390/ijms221910572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wu L, Li G, Feng D, Qin H, Gong L, Zhang J, Zhang Z. MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol 2013;8:200. [PMID: 24326156 DOI: 10.1186/1746-1596-8-200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
24 Tűzesi Á, Kling T, Wenger A, Lunavat TR, Jang SC, Rydenhag B, Lötvall J, Pollard SM, Danielsson A, Carén H. Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells. Oncotarget 2017;8:90164-75. [PMID: 29163818 DOI: 10.18632/oncotarget.21621] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
25 An X, Sarmiento C, Tan T, Zhu H. Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sin B 2017;7:38-51. [PMID: 28119807 DOI: 10.1016/j.apsb.2016.09.002] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 14.7] [Reference Citation Analysis]
26 Henriksen M, Johnsen KB, Andersen HH, Pilgaard L, Duroux M. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. Mol Neurobiol 2014;50:896-913. [PMID: 24619503 DOI: 10.1007/s12035-014-8668-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
27 Qin X, Chen J, Wu L, Liu Z. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma. Biomed Pharmacother 2017;89:742-50. [PMID: 28273636 DOI: 10.1016/j.biopha.2017.02.062] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
28 Yang X, Zhong X, Tanyi JL, Shen J, Xu C, Gao P, Zheng TM, DeMichele A, Zhang L. mir-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells. Biochem Biophys Res Commun. 2013;431:617-622. [PMID: 23274497 DOI: 10.1016/j.bbrc.2012.12.083] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
29 Deng L, Zhai X, Liang P, Cui H. Overcoming TRAIL Resistance for Glioblastoma Treatment. Biomolecules 2021;11:572. [PMID: 33919846 DOI: 10.3390/biom11040572] [Reference Citation Analysis]
30 Mahjoor M, Afkhami H, Mollaei M, Nasr A, Shahriary S, Khorrami S. MicroRNA-30c delivered by bone marrow-mesenchymal stem cells induced apoptosis and diminished cell invasion in U-251 glioblastoma cell line. Life Sci 2021;279:119643. [PMID: 34048811 DOI: 10.1016/j.lfs.2021.119643] [Reference Citation Analysis]
31 Calzolari A, Saulle E, De Angelis ML, Pasquini L, Boe A, Pelacchi F, Ricci-Vitiani L, Baiocchi M, Testa U. Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines. PLoS One. 2014;9:e94438. [PMID: 24740347 DOI: 10.1371/journal.pone.0094438] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
32 Chen GH, Xu J, Yang YJ. Exosomes: promising sacks for treating ischemic heart disease? Am J Physiol Heart Circ Physiol 2017;313:H508-23. [PMID: 28646026 DOI: 10.1152/ajpheart.00213.2017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
33 Aloizou AM, Pateraki G, Siokas V, Mentis AA, Liampas I, Lazopoulos G, Kovatsi L, Mitsias PD, Bogdanos DP, Paterakis K, Dardiotis E. The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention? Toxicol Rep 2020;7:1514-30. [PMID: 33251119 DOI: 10.1016/j.toxrep.2020.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Wang K, An T, Zhou LY, Liu CY, Zhang XJ, Feng C, Li PF. E2F1-regulated miR-30b suppresses Cyclophilin D and protects heart from ischemia/reperfusion injury and necrotic cell death. Cell Death Differ 2015;22:743-54. [PMID: 25301066 DOI: 10.1038/cdd.2014.165] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
35 di Gennaro A, Damiano V, Brisotto G, Armellin M, Perin T, Zucchetto A, Guardascione M, Spaink HP, Doglioni C, Snaar-Jagalska BE, Santarosa M, Maestro R. A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness. Cell Death Differ 2018;25:2165-80. [PMID: 29666469 DOI: 10.1038/s41418-018-0103-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
36 Zhang Q, Yu L, Qin D, Huang R, Jiang X, Zou C, Tang Q, Chen Y, Wang G, Wang X, Gao X. Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One 2015;10:e0120698. [PMID: 25799050 DOI: 10.1371/journal.pone.0120698] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
37 Mao C, Zhang J, Lin S, Jing L, Xiang J, Wang M, Wang B, Xu P, Liu W, Song X, Lv C. MiRNA-30a inhibits AECs-II apoptosis by blocking mitochondrial fission dependent on Drp-1. J Cell Mol Med 2014;18:2404-16. [PMID: 25284615 DOI: 10.1111/jcmm.12420] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
38 Tsukasa K, Ding Q, Miyazaki Y, Matsubara S, Natsugoe S, Takao S. miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells. Hum Cell 2016;29:130-7. [PMID: 26965588 DOI: 10.1007/s13577-016-0137-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
39 Rencelj A, Gvozdenovic N, Cemazar M. MitomiRs: their roles in mitochondria and importance in cancer cell metabolism. Radiol Oncol 2021;55:379-92. [PMID: 34821131 DOI: 10.2478/raon-2021-0042] [Reference Citation Analysis]
40 Yang XJ, Si RH, Liang YH, Ma BQ, Jiang ZB, Wang B, Gao P. Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway. World J Gastroenterol 2016; 22(15): 3978-3991 [PMID: 27099441 DOI: 10.3748/wjg.v22.i15.3978] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
41 Zhang L, Li J, Cui L, Shang J, Tian F, Wang R, Xing G. MicroRNA-30b promotes lipopolysaccharide-induced inflammatory injury and alleviates autophagy through JNK and NF-κB pathways in HK-2 cells. Biomed Pharmacother 2018;101:842-51. [PMID: 29635893 DOI: 10.1016/j.biopha.2018.02.085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
42 Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A, deVere White RW, Kung HJ. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene. 2014;33:2495-2503. [PMID: 23728339 DOI: 10.1038/onc.2013.200] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 10.4] [Reference Citation Analysis]
43 Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv G, Zou Z, Jiang XC, Zou C, Liu W, Luo J, Zhao Z, Muhammad S, Wang G, Chen YG, Wang X. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol Cell Biol 2015;35:988-1000. [PMID: 25582198 DOI: 10.1128/MCB.01242-14] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
44 Tumilson CA, Lea RW, Alder JE, Shaw L. Circulating microRNA biomarkers for glioma and predicting response to therapy. Mol Neurobiol 2014;50:545-58. [PMID: 24696266 DOI: 10.1007/s12035-014-8679-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
45 Lee TJ, Haque F, Shu D, Yoo JY, Li H, Yokel RA, Horbinski C, Kim TH, Kim SH, Kwon CH, Nakano I, Kaur B, Guo P, Croce CM. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget 2015;6:14766-76. [PMID: 25885522 DOI: 10.18632/oncotarget.3632] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 9.2] [Reference Citation Analysis]
46 Lin C, Li X, Zhang Y, Guo Y, Zhou J, Gao K, Dai J, Hu G, Lv L, Du J, Zhang Y. The microRNA feedback regulation of p63 in cancer progression. Oncotarget 2015;6:8434-53. [PMID: 25726529 DOI: 10.18632/oncotarget.3020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
47 Zhong K, Chen K, Han L, Li B. MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer 2014;14:703. [PMID: 25249344 DOI: 10.1186/1471-2407-14-703] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
48 Che S, Sun T, Wang J, Jiao Y, Wang C, Meng Q, Qi W, Yan Z. miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway. Tumor Biol 2015;36:6805-11. [DOI: 10.1007/s13277-015-3400-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
49 Zhu J, Zhou Q, Tan S. Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer. Cancer Lett 2016;383:154-60. [PMID: 27693456 DOI: 10.1016/j.canlet.2016.09.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
50 Ingenito F, Roscigno G, Affinito A, Nuzzo S, Scognamiglio I, Quintavalle C, Condorelli G. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications. Int J Mol Sci. 2019;20. [PMID: 31546654 DOI: 10.3390/ijms20194687] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 13.0] [Reference Citation Analysis]
51 Li XH, Ha CT, Fu D, Landauer MR, Ghosh SP, Xiao M. Delta-tocotrienol suppresses radiation-induced microRNA-30 and protects mice and human CD34+ cells from radiation injury. PLoS One 2015;10:e0122258. [PMID: 25815474 DOI: 10.1371/journal.pone.0122258] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
52 Pek SL, Tavintharan S, Woon K, Lin L, Ong CN, Lim SC, Sum CF. MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation. Exp Biol Med (Maywood) 2016;241:317-30. [PMID: 26429200 DOI: 10.1177/1535370215605588] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
53 Zhang Y, Chen J, Xue Q, Wang J, Zhao L, Han K, Zhang D, Hou L. Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis. Biomed Res Int 2019;2019:4015969. [PMID: 31032345 DOI: 10.1155/2019/4015969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
54 Arghiani N, Matin MM. miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy. Nucleic Acid Ther 2021;31:271-83. [PMID: 33891511 DOI: 10.1089/nat.2020.0914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Zhang X, Wang L, Liu Y, Huang W, Cheng D. MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1. Biomed Pharmacother. 2018;99:523-529. [PMID: 29665655 DOI: 10.1016/j.biopha.2018.01.076] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
56 Lin X, Beckers E, Mc Cafferty S, Gansemans Y, Joanna Szymańska K, Chaitanya Pavani K, Catani JP, Van Nieuwerburgh F, Deforce D, De Sutter P, Van Soom A, Peelman L. Bovine Embryo-Secreted microRNA-30c Is a Potential Non-invasive Biomarker for Hampered Preimplantation Developmental Competence. Front Genet 2019;10:315. [PMID: 31024625 DOI: 10.3389/fgene.2019.00315] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
57 Beer L, Seemann R, Ristl R, Ellinger A, Kasiri MM, Mitterbauer A, Zimmermann M, Gabriel C, Gyöngyösi M, Klepetko W, Mildner M, Ankersmit HJ. High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells. BMC Genomics 2014;15:814. [PMID: 25257395 DOI: 10.1186/1471-2164-15-814] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
58 Fischer S, Buck T, Wagner A, Ehrhart C, Giancaterino J, Mang S, Schad M, Mathias S, Aschrafi A, Handrick R, Otte K. A functional high-content miRNA screen identifies miR-30 family to boost recombinant protein production in CHO cells. Biotechnol J 2014;9:1279-92. [PMID: 25061012 DOI: 10.1002/biot.201400306] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
59 Han F, Huo Y, Huang CJ, Chen CL, Ye J. MicroRNA-30b promotes axon outgrowth of retinal ganglion cells by inhibiting Semaphorin3A expression. Brain Res 2015;1611:65-73. [PMID: 25791621 DOI: 10.1016/j.brainres.2015.03.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
60 Ma X, Choudhury SN, Hua X, Dai Z, Li Y. Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway. Carcinogenesis 2013;34:1216-23. [PMID: 23385064 DOI: 10.1093/carcin/bgt044] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
61 Liao WT, Ye YP, Zhang NJ, Li TT, Wang SY, Cui YM, Qi L, Wu P, Jiao HL, Xie YJ, Zhang C, Wang JX, Ding YQ. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J Pathol 2014;232:415-27. [PMID: 24293274 DOI: 10.1002/path.4309] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 12.4] [Reference Citation Analysis]
62 Qiao F, Zhang K, Gong P, Wang L, Hu J, Lu S, Fan H. Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis. Mol Biol Rep. 2014;41:5693-5700. [PMID: 24913034 DOI: 10.1007/s11033-014-3439-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
63 Li Z, Guo J, Ma Y, Zhang L, Lin Z. Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2. Oncol Res 2018;26:219-30. [PMID: 28550683 DOI: 10.3727/096504017X14944585873659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
64 Sánchez-Jiménez C, Carrascoso I, Barrero J, Izquierdo JM. Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling. BMC Mol Biol 2013;14:4. [PMID: 23387986 DOI: 10.1186/1471-2199-14-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
65 Calore F, Lovat F, Garofalo M. Non-coding RNAs and cancer. Int J Mol Sci 2013;14:17085-110. [PMID: 23965974 DOI: 10.3390/ijms140817085] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
66 Markou A, Zavridou M, Lianidou ES. miRNA-21 as a novel therapeutic target in lung cancer. Lung Cancer (Auckl) 2016;7:19-27. [PMID: 28210157 DOI: 10.2147/LCTT.S60341] [Cited by in Crossref: 11] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
67 Tivnan A, McDonald KL. Current progress for the use of miRNAs in glioblastoma treatment. Mol Neurobiol 2013;48:757-68. [PMID: 23625340 DOI: 10.1007/s12035-013-8464-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
68 Alexiou GA, Tsamis KI, Kyritsis AP. Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas. Semin Pediatr Neurol 2015;22:35-9. [PMID: 25976259 DOI: 10.1016/j.spen.2014.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
69 Qi B, Wang Y, Chen ZJ, Li XN, Qi Y, Yang Y, Cui GH, Guo HZ, Li WH, Zhao S. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway. World J Gastroenterol 2017; 23(45): 7965-7977 [PMID: 29259372 DOI: 10.3748/wjg.v23.i45.7965] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
70 Guo Y, Hong W, Wang X, Zhang P, Körner H, Tu J, Wei W. MicroRNAs in Microglia: How do MicroRNAs Affect Activation, Inflammation, Polarization of Microglia and Mediate the Interaction Between Microglia and Glioma? Front Mol Neurosci 2019;12:125. [PMID: 31133802 DOI: 10.3389/fnmol.2019.00125] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
71 Liu W, Li H, Wang Y, Zhao X, Guo Y, Jin J, Chi R. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma. Gene 2017;626:275-81. [PMID: 28536082 DOI: 10.1016/j.gene.2017.05.040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
72 Yu W, Liang S, Zhang C. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma. Neuromolecular Med 2018;20:452-74. [PMID: 30182330 DOI: 10.1007/s12017-018-8507-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
73 Jian Y, Xu CH, Li YP, Tang B, Xie SH, Zeng EM. Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK. Biosci Rep 2019;39:BSR20182226. [PMID: 31270250 DOI: 10.1042/BSR20182226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
74 Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L, Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, Ming ZJ, Li B, Chen B, Wang JR, Liu YB, Yang JM. Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin. Biochem Pharmacol 2014;87:562-70. [PMID: 24345332 DOI: 10.1016/j.bcp.2013.12.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.7] [Reference Citation Analysis]
75 Mizuno K, Mataki H, Seki N, Kumamoto T, Kamikawaji K, Inoue H. MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis. J Hum Genet 2017;62:57-65. [PMID: 27488441 DOI: 10.1038/jhg.2016.98] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
76 Donnarumma E, Fiore D, Nappa M, Roscigno G, Adamo A, Iaboni M, Russo V, Affinito A, Puoti I, Quintavalle C, Rienzo A, Piscuoglio S, Thomas R, Condorelli G. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget 2017;8:19592-608. [PMID: 28121625 DOI: 10.18632/oncotarget.14752] [Cited by in Crossref: 166] [Cited by in F6Publishing: 168] [Article Influence: 33.2] [Reference Citation Analysis]
77 Bhere D, Arghiani N, Lechtich ER, Yao Y, Alsaab S, Bei F, Matin MM, Shah K. Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy. Sci Rep 2020;10:1779. [PMID: 32019988 DOI: 10.1038/s41598-020-58072-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
78 Marin I, Ofek E, Bar J, Prisant N, Perelman M, Avivi C, Lavy-Shahaf G, Onn A, Katz R, Barshack I. MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study. J Clin Pathol 2020;73:636-41. [PMID: 32060074 DOI: 10.1136/jclinpath-2019-206420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
79 Li M, Li J, Liu L, Li W, Yang Y, Yuan J. MicroRNA in Human Glioma. Cancers (Basel) 2013;5:1306-31. [PMID: 24202447 DOI: 10.3390/cancers5041306] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]